Mylan Wins Bid To Block Apotex's Generic Paxil

Law360, New York (September 21, 2010, 12:10 PM EDT) -- Mylan Inc. won an order Tuesday barring Apotex Inc. from making a generic form of GlaxoSmithKline PLC's Paxil, in a suit that accuses the brand-name drugmaker and Apotex of seeking to put out a rival copycat version of the anti-depressant in breach of an exclusivity agreement.

Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey enjoined Apotex from manufacturing or marketing the drug until an Oct. 18 hearing on the matter.

Mylan filed suit Monday, claiming the sole right to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.